RENAISSANCE TECHNOLOGIES LLC
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in PLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,553,680
-$104,136 QoQ
Shares Held
1,096,000
-10.5% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 101 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. PLX ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in PLX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,553,680 | 1,096,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,657,816 | 1,224,800 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,273,940 | 1,263,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,920,188 | 1,315,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,390,204 | 1,615,003 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,043,719 | 1,188,953 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,101,840 | 1,118,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $975,018 | 955,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $941,382 | 804,600 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,039,122 | 824,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,184,768 | 665,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,031,026 | 621,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,318,600 | 659,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,540,475 | 1,209,750 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $307,706 | 224,603 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $121,888 | 117,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $125,132 | 114,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,614 | 11,900 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $57,443 | 30,075 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,264,047 | 507,634 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,773,741 | 488,634 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,897,592 | 490,334 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,010,344 | 530,434 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,121,969 | 477,434 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||